An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.

Department of Psychiatry, University of British Columbia, Vancouver, Canada.
The Journal of Clinical Psychiatry (Impact Factor: 5.14). 03/2001; 62(3):164-8. DOI: 10.4088/JCP.v62n0305
Source: PubMed

ABSTRACT Many patients with seasonal affective disorder (SAD) have dysfunctional eating behaviors. Conversely, many women with bulimia nervosa have marked winter worsening of mood and bulimic symptoms. Controlled studies of light therapy in SAD and in bulimia nervosa have shown beneficial effects on mood and binge/purge symptoms. We explored the clinical use of light therapy in women with SAD who also had comorbid bulimia nervosa.
Twenty-two female patients diagnosed using DSM-IV criteria with both bulimia nervosa and major depressive disorder with a seasonal (winter) pattern were treated with an open design, 4-week trial of light therapy (10,000 lux fluorescent light box with an ultraviolet filter, 30 to 60 minutes per day in the early morning). Patients were assessed before and after treatment with depression scales and with binge/purge diaries.
Light therapy resulted in significant improvement in mood, with a mean 56% reduction in 29-item Hamilton Rating Scale for Depression scores following treatment (p < .001). The frequency of binges and purges per week also significantly decreased (p < .001) from baseline by a mean of 46% and 36%, respectively. Two (9%) of 22 patients became abstinent of binge/ purge episodes, compared with 10 (45%) of 22 patients who met criteria for remission of depressive symptoms. The light therapy was well tolerated by patients.
These results suggest that therapeutic effects of light therapy on mood and bulimic symptoms in patients with SAD and comorbid bulimia nervosa are sustained over at least 4 weeks. However, the low abstinence rate in bulimic symptoms indicates that light therapy may be most effectively used as an adjunctive treatment to medications and/or psychotherapy for bulimia nervosa.

  • [Show abstract] [Hide abstract]
    ABSTRACT: IntroductionLight therapy is a therapeutic technique based on the use of light. Its use in Psychiatry has grown over the past 30 years since the discovery of its efficacy in the treatment of seasonal affective disorder. Its mechanism of action is related to the chronobiology of circadian rhythms and to the role of melatonin in the modulation of endogenous rhythms. This article provides a critical review of the literature dealing with the use of this treatment in seasonal depression and other mood disorders (nonseasonal depression and bipolar disorder), in eating disorders, and other psychiatric syndromes.
    Quaderni Italiani di Psychiatria 12/2010; 29(4):134-139. DOI:10.1016/j.quip.2010.10.002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and Objectives: Recent decades have seen significant advances in the knowledge of pathogenesis of mood disorders, as well as of other conditions directly or indirectly related to such diseases. Such progress has led to the emergence of new treatments, such as bright light therapy, based on the discovery of the therapeutic effects of exposure to bright light with the so-called seasonal affective disorder (SAD), a DSM seasonal pattern specifier linked to major depression and bipolar disorder recurrent describing the course of illness during seasons. The goal of the present work is to review the potential clinical applications of phototherapy, including SAD, obsessive-compulsive disorder, bulimia, premenstrual syndrome, non seasonal major depression, sleep disorders, jet-lag, dementia, normal populations and in primary care. Methods: A systematic review of the literature about this matter since the early Rosenthal,s group observations has been carried out. Results: A considerable number of studies has been published about this therapeutic approach, pointing that not only depression but also other pathologies that may follow a seasonal pattern could benefit from phototherapy integrated with more standard treatments, as well as other disorders directly or indirectly related to mood, and even another conditions without a seasonal pattern. Conclusions: The data about the different uses of this treatment neither confirm nor dismiss its efficacy, stating that the therapy should still be regarded as experimental. Future studies should continue investigating to draw reliable conclusions about the usefulness of bright light therapy on mood disorders and other conditions to provide an alternative to standard treatments almost exclusively based on psychoactive drugs.
    European Journal of Psychiatry 01/2009; 23(3). DOI:10.4321/S0213-61632009000300005 · 0.46 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To provide a comprehensive review of pharmacotherapy and other biological treatments for eating disorders. Literature on this topic was systematically reviewed. The bulimia nervosa (BN) literature underscores the utility of antidepressants, particularly SSRIs, in improving the symptoms of the disorder. The literature on binge eating disorder supports efficacy on reduction in binge eating frequency for a variety of compounds. However, such compounds have only modest effects on weight. Certain antiepileptic agents such as topiramate, if tolerated, are probably more useful in terms of weight loss. The number of controlled trials in patients with anorexia nervosa (AN) in particular has been quite small, and recent meta-analyses show disappointing results using atypical antipsychotics in AN. The pharmacological treatment of eating disorders remains an underdeveloped field although drug therapy clearly plays a role in the treatment of those with BN and binge eating disorder. Other biological therapies have not been adequately studied. © 2013 by Wiley Periodicals, Inc. (Int J Eat Disord 2013; 46:470-477).
    International Journal of Eating Disorders 07/2013; 46(5):470-7. DOI:10.1002/eat.22104 · 3.03 Impact Factor